Top Stories: Calithera Biosciences (NASDAQ:CALA), Protalix BioTherapeutics (NYSEMKT:PLX), KaloBios Pharmaceuticals (NASDAQ:KBIO), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG)

On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $12.14. Company’s EPS growth for next 5 years is recorded as 75.00%.Calithera Biosciences, Inc. (NASDAQ:CALA) announced its participated at the Bank of America Merrill Lynch 2015 Healthcare Conference, on Tuesday, May 12, 2015 at 8:00 a.m. Pacific Time at The Encore at Wynn Hotel in Las Vegas, NV.

Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) in last trading activity decreased -0.94% to close at $2.10. Company weekly performance is -0.47% while its quarterly performance stands at 11.70%. Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) is -50.00% away from its 52 week high. Protalix BioTherapeutics, Inc. (NYSE:PLX) announced that Moshe Manor, the Company’s President and Chief Executive Officer, will present a corporate overview at the 2015 UBS Global Healthcare Conference on Wednesday, May 20, 2015 at 10:30 AM ET, at The Sheraton New York Times Square Hotel, New York, NY.

On last trading day KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) decreased -1.82% to close at $0.48. Its volatility for the week is 6.51% while volatility for the month is 8.29%. KBIO’s EPS growth for past 5 years was 42.90%. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) monthly performance is -9.23%. On May 11, KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) reported its financial results for the first quarter of 2015. Net loss for the quarter ended March 31, 2015 was $9.6 million or $0.29 per common share, as compared to $10.4 million or $0.32 per common share for the same period in 2014.

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) has 1.40% insider ownership while its institutional ownership stands at 76.10%. In last trading activity company’s stock closed at $10.22. Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) announced that Greg Madison, the Company’s Chief Executive Officer, presented a company overview, including progress with the commercialization of Auryxia™ (ferric citrate) in the United States, at the Bank of America Merrill Lynch 2015 Health Care Conference, held at the Encore at the Wynn in Las Vegas, NV on May 12-14, 2015.

On last trading day TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) decreased -4.35% to close at $2.42. Its volatility for the week is 13.17% while volatility for the month is 17.68%. TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) monthly performance is -43.72%. Stock analysts at Needham & Company LLC lowered their price target on shares of Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) from $10.00 to $7.00 in a report issued on Thursday. The firm currently has a “buy” rating on the stock.

Investors Watch List: Calithera Biosciences (NASDAQ:CALA), Relypsa (NASDAQ:RLYP), DreamWorks Animation SKG Inc. (NASDAQ:DWA), Resolute Energy Corporation (NYSE:REN), Ford Motor (NYSE:F)

On Friday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $13.87. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences Inc (NADAQ:CALA) declared its financial results for the first quarter ended March 31, 2015. As of March 31, 2015, cash, cash equivalents and investments totaled $94.3 million. “During the first quarter, we continued to advance and expand our development pipeline,” said Susan Molineaux, PhD, President and Chief Executive Officer of Calithera.

Relypsa, Inc. (NASDAQ:RLYP) in last trading activity advanced 15.36% to close at $34.54. Company weekly performance is 13.96% while its quarterly performance stands at 5.56%. Relypsa, Inc. (NASDAQ:RLYP) is -18.27% away from its 52 week high. Relypsa, Inc. (NASDAQ:RLYP) reported financial results for the quarter ended March 31, 2015. Net loss for the first quarter 2015 was $29.7 million, or $0.78 per share, compared to $16.1 million, or $0.54 per share, for the comparable period in 2014. Cash, cash equivalents and investments totaled $324.3 million at March 31, 2015, compared to $135.8 million at December 31, 2014. Shares outstanding as of March 31, 2015 were 41.4 million.

On last trading day DreamWorks Animation SKG Inc. (NASDAQ:DWA) decreased -0.41% to close at $24.24. Its volatility for the week is 4.29% while volatility for the month is 3.53%. DWA’s sales growth for past 5 years was -1.10% and its EPS growth for past 5 years was -32.70%. DreamWorks Animation SKG Inc. (NASDAQ:DWA) monthly performance is -5.05%. On 30 April, DreamWorks Animation Inc. (NASDAQ:DWA) reported a worse-than-expected operating loss of $35.3 million or 64 cents per share, in the quarter ended March 31, 2015. The animation company, known for successful movie franchises such as Shrek, Madagascar, and Kung Fu Panda, is in the middle of massive restructuring and had to account for related charges of $31.9 million or a per share loss of $0.37. The charges break-up includes $6.1 million towards employee termination packages and other employee expenses; $9.3 million to pay for accelerated depreciation and amortization charges from closing down the Redwood City studio in California and $16.5 million went towards costs associated with cutting down its feature films slate for the year from three films to two.

Resolute Energy Corporation (NYSE:REN) has 5.40% insider ownership while its institutional ownership stands at 81.60%. In last trading activity company’s stock closed at $1.27. Resolute Energy Corp (NYSE:REN)‘s stock had its “hold” rating reaffirmed by Zacks in a research note issued on Thursday.

On last trading day Ford Motor Co. (NYSE:F) advanced 1.03% to close at $15.67. Its volatility for the week is 1.60% while volatility for the month is 1.33%. F’s sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was -1.40%. Ford Motor Co. (NYSE:F) monthly performance is -0.83%. Ford Motor Co. (NYSE:F) said Monday it will bring back two popular trim levels on its 2016 Mustang, which will hit dealer lots in the third quarter of this year.

Top Stories: Cerus Corporation (NASDAQ:CERS), Calithera Biosciences (NASDAQ:CALA), Toyota Motor Corporation (NYSE:TM), Comcast Corporation (NASDAQ:CMCSA), IAMGOLD Corp. (NYSE:IAG)

On Tuesday shares of Cerus Corporation (NASDAQ:CERS) closed at $4.49. Cerus Corporation (NASDAQ:CERS) announced financial results for the first quarter ended March 31, 2015. Revenue for the first quarter of 2015 was $7.7 million, reflecting an increase in INTERCEPT disposable kit demand of 17% and a 2% decrease in reported revenue from the first quarter of 2014.

Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity moved down -3.65% to close at $9.50. Company weekly performance is -14.07% while its quarterly performance stands at -51.75%. Calithera Biosciences, Inc. (NASDAQ:CALA) is -71.62% away from its 52 week high. Zacks upgraded shares of Calithera Biosciences (NASDAQ:CALA) from a sell rating to a hold rating in a research report sent to investors on Friday morning.

On last trading day Toyota Motor Corporation (NYSE:TM) moved down -1.79% to close at $137.55. Its volatility for the week is 1.22% while volatility for the month is 0.74%. TM’s sales growth for past 5 years was 4.60% and its EPS growth for past 5 years was 43.70%. Toyota Motor Corporation (NYSE:TM) monthly performance is -2.20%. On May 01, Toyota Motor Corporation (NYSE:TM) Sales (TMS), U.S.A., reported April 2015 sales of 203,329 units, an increase of 1.8 percent from April 2014 on a volume basis. With the same amount of selling days in April 2015 and April 2014, sales were up 1.8 percent on a daily selling rate (DSR) basis.

On Tuesday shares of Comcast Corporation (NASDAQ:CMCSA) closed at $57.98. Company’s sales growth for last 5 years was 14.00% and EPS growth for next 5 years is recorded as 17.00%. Cable television giant Comcast Corp. (NASDAQ:CMCSA) announced a new, multi-year plan to reinvent the customer experience. It plans to create more than 5,500 customer service jobs over the next few years and set a goal to always be on time for customer appointments by third-quarter of 2015.

IAMGOLD Corp. (NYSE:IAG) in last trading activity remains unchanged to close at $2.28. Company quarterly performance stands at -10.59%. IAMGOLD Corp. (NYSE:IAG) is -46.60% away from its 52 week high. IAMGOLD Corporation (NYSE:IAG) reports its financial and operating results for the first quarter ended March 31, 2015. Revenues from continuing operations for the first quarter 2015 were $244.7 million, up 13% from the same prior year period.

Why Making Dramatic Moves: Calithera Biosciences (NASDAQ:CALA), Bio-Techne Corp. (NASDAQ:TECH), Edgewater Technology Inc. (NASDAQ:EDGW), DreamWorks Animation (NASDAQ:DWA), Century Aluminum (NASDAQ:CENX)

On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $10.01. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA) announced that the Company’s first quarter 2015 financial results will be released on Thursday, May 7, 2015.

Bio-Techne Corp. (NASDAQ:TECH) in last trading activity moved down -2.48% to close at $95.96. Company weekly performance is -6.59% while its quarterly performance stands at 2.19%. Bio-Techne Corp. (NASDAQ:TECH) is -6.83% away from its 52 week high. On April 23, Bio-Techne Corporation (NASDAQ:TECH) announced that management will host a conference call on Tuesday, May 5, 2015, at 8:00 a.m. CDT to review third quarter fiscal 2015 financial results.

On last trading day Edgewater Technology Inc. (NASDAQ:EDGW) advanced 0.71% to close at $7.05. Its volatility for the week is 2.02% while volatility for the month is 2.11%. EDGW’s sales growth for past 5 years was 17.70% and its EPS growth for past 5 years was 24.30%. Edgewater Technology Inc. (NASDAQ:EDGW) monthly performance is 3.52%. Edgewater Technology, Inc. (NASDAQ:EDGW), reported financial results for the first quarter ended March 31, 2015. Total revenue was $26.6 million compared to $27.6 million; and Service revenue was $22.7 million compared to $23.5 million.

On Thursday shares of DreamWorks Animation SKG Inc. (NASDAQ:DWA) closed at $26.06. Company’s sales growth for last 5 years was -1.10% and EPS growth for next 5 years is recorded as 17.50%. DreamWorks Animation SKG, Inc. (NASDAQ:DWA) reported a net loss for the first quarter of $54.8 million or $0.64 per share, compared to a net loss of $42.9 million or $0.51 per share for the year-ago quarter.

Century Aluminum Co. (NASDAQ:CENX) in last trading activity fell -1.60% to close at $12.89. Company weekly performance is -0.39% while its quarterly performance stands at -46.09%. Century Aluminum Co. (NASDAQ:CENX) is -59.40% away from its 52 week high. Century Aluminum Co. (NASDAQ:CENX) on Thursday reported first-quarter net income of $67.8 million, after reporting a loss in the same period a year earlier.

Active Stocks to Watch: KeyCorp. (NYSE:KEY), Calithera Biosciences (NASDAQ:CALA), SunTrust Banks (NYSE:STI), AbbVie Inc. (NYSE:ABBV), Windstream Holdings (NASDAQ:WIN)

On Friday shares of KeyCorp. (NYSE:KEY) closed at $14.23. Company’s sales growth for last 5 years was -7.60% and EPS growth for next 5 years is recorded as 9.69%. Announced April 16, that Cleveland-based KeyCorp. (NYSE:KEY), said its profit edged down in the first quarter but it expects improvement later this year on increasing investment-banking fees and plans to expand its residential-mortgage business. KeyCorp said it experienced strong overall loan growth of 5.1% in the first quarter from the year earlier as its revenue grew slightly.

Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity fell -2.54% to close at $13.41. Company weekly performance is -27.00% while its quarterly performance stands at -31.93%. Calithera Biosciences, Inc. (NASDAQ:CALA) is -59.95% away from its 52 week high. On Apr 22, Calithera Biosciences, Inc. (NASDAQ:CALA) announced that clinical data for its lead drug candidate CB-839, the Company’s novel, orally bioavailable glutaminase inhibitor, will be presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held from May 29 to June 2, 2015 in Chicago, Illinois.

On last trading day SunTrust Banks, Inc. (NYSE:STI) fell -1.08% to close at $40.47. Its volatility for the week is 1.40% while volatility for the month is 1.37%. STI’s sales growth for past 5 years was -4.30% and its EPS growth for past 5 years was 23.00%. SunTrust Banks, Inc. (NYSE:STI) monthly performance is -0.17%. SunTrust Banks Inc. (NYSE:STI), Apollo Global Management and Ares Management LP are considering offers for a General Electric Co. unit in the U.S. that lends to private-equity firms, Bloomberg reported citing people familiar with the matter.

AbbVie Inc. (NYSE:ABBV) has 0.10% insider ownership while its institutional ownership stands at 73.10%. In last trading activity company’s stock closed at $66.07. AbbVie (NYSE:ABBV) announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study. RUBY-I is evaluating VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) with or without ribavirin (RBV) in treatment-naïve, non-cirrhotic, genotype 1 (GT1) chronic hepatitis C patients with severe renal impairment (stage 4 or 5), including those on hemodialysis.

On last trading day Windstream Holdings, Inc. (NASDAQ:WIN) fell -5.55% to close at $7.83. Its volatility for the week is 4.19% while volatility for the month is 3.55%. WIN’s sales growth for past 5 years was 14.20% and its EPS growth for past 5 years was -15.70%. Windstream Holdings, Inc. (NASDAQ:WIN) monthly performance is 3.16%. On April 24, Windstream Holdings, Inc. (NASDAQ:WIN) announced that its wholly owned-subsidiaries, Windstream Services, LLC (Windstream) and PAETEC Holding, LLC (PAETEC), are calling for redemption certain of their outstanding notes on May 27, 2015.

Top News: The PNC Financial Services Group (NYSE:PNC), Calithera Biosciences (NASDAQ:CALA), pSivida Corp. (NASDAQ:PSDV), MBIA Inc. (NYSE:MBI), Lazard (NYSE:LAZ)

On Tuesday shares of The PNC Financial Services Group, Inc. (NYSE:PNC) closed at $93.62. Company’s sales growth for last 5 years was -4.80% and EPS growth for next 5 years is recorded as 5.88%. The PNC Financial Services Group, Inc. (NYSE:PNC) reported first-quarter net income to common shares of $926 million or $1.75 per share, compared to $983 million or $1.82 per share, prior year. The company said its first-quarter earnings reflected average loan and deposit growth, disciplined expense management, modestly improved credit quality and seasonal client trends.

Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity advanced 4.59% to close at $18.93. Company weekly performance is 9.74% while its quarterly performance stands at -17.19%. Calithera Biosciences, Inc. (NASDAQ:CALA) is -43.46% away from its 52 week high. On Apr 09, Calithera Biosciences, Inc. (NASDAQ:CALA) announced its participation at the 14th Annual Needham Healthcare Conference. William D. Waddill, Senior Vice President and Chief Financial Officer will present on Wednesday, April 15, 2015 at 3:40 p.m. Eastern Time at The Westin New York Grand Central Hotel in New York, NY.

On last trading day pSivida Corp. (NASDAQ:PSDV) fell -2.62% to close at $4.09. Its volatility for the week is 3.05% while volatility for the month is 3.98%. PSDV’s sales growth for past 5 years was -22.10% and its EPS growth for past 5 years was -28.50%. pSivida Corp. (NASDAQ:PSDV) monthly performance is -4.88%. pSivida Corp. (NASDAQ:PSDV) has been granted marketing authorisation for its ILUVIEN eye disease treatment in Poland. This marks the completion of the latest round of European Union authorisations with the treatment for vision impairment associated with diabetic macular edema now approved in 17 countries.

MBIA Inc. (NYSE:MBI) has 3.10% insider ownership while its institutional ownership stands at 94.60%. In last trading activity company’s stock closed at $9.57.

On last trading day Lazard Ltd. (NYSE:LAZ) advanced 0.33% to close at $55.34. Its volatility for the week is 2.57% while volatility for the month is 2.34%. LAZ’s sales growth for past 5 years was 7.60% and its EPS growth for past 5 years was 31.30%. Lazard Ltd. (NYSE:LAZ) monthly performance is 12.23%. Sandler O’Neill cut shares of Lazard (NYSE:LAZ) from a buy rating to a hold rating in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports.

Stock Runners: PetroQuest Energy Inc. (NYSE:PQ), Calithera Biosciences (NASDAQ:CALA), Willbros Group Inc. (NYSE:WG), Baidu Inc (ADR) (NASDAQ:BIDU), Tremor Video (NYSE:TRMR)

On Wednesday shares of PetroQuest Energy Inc. (NYSE:PQ) closed at $2.40. Company’s sales growth for last 5 years was 0.60% and EPS growth for next 5 years is recorded as 29.00%. PetroQuest Energy, Inc. (NYSE: PQ) announced on 31 March 2015, that the Company’s bank group has completed its semi-annual re-determination of its borrowing base under its credit facility. As a result, the Company’s $220 million borrowing base has been revised to $190 million, subject to the aggregate commitments of the bank group, which the Company elected to remain unchanged at $170 million.

Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity advanced 5.68% to close at $18.23. Company weekly performance is 11.02% while its quarterly performance stands at -23.56%. Calithera Biosciences, Inc. (NASDAQ:CALA) is -45.55% away from its 52 week high. On 26 March, Calithera Biosciences, Inc. (NASDAQ:CALA) announced Loss from operations for the three months and year end ended December 31, 2014 was $6.8 million and $21.7 million, respectively. Cash and cash equivalents totaled $102.0 million at December 31, 2014. In October 2014, Calithera raised net proceeds of $71.6 million in its initial public offering.

On last trading day Willbros Group Inc. (NYSE:WG) fell -1.75% to close at $2.81. Its volatility for the week is 12.34% while volatility for the month is 13.52%. WG’s sales growth for past 5 years was 11.30% and its EPS growth for past 5 years was -33.50%. Willbros Group Inc. (NYSE:WG) monthly performance is -53.55%. On 1 April 2015, Houston-based energy contractor Willbros Group Inc. (NYSE: WG) has sold another subsidiary as it works to reduce its debt, and it has reached an agreement that alleviates the “substantial doubt” about its ability to continue operating.

Baidu Inc (ADR) (NASDAQ:BIDU) has 0.13% insider ownership while its institutional ownership stands at 82.80%. In last trading activity company’s stock closed at $212.84. Vetr cut shares of Baidu (NASDAQ:BIDU) from a strong-buy rating to a buy rating in a research report sent to investors on Monday.

On last trading day Tremor Video, Inc. (NYSE:TRMR) advanced 3.83% to close at $2.44. Its volatility for the week is 6.02% while volatility for the month is 5.68%. Tremor Video, Inc. (NYSE:TRMR) monthly performance is 1.24%. On 3 April 2015, Tremor Video, Inc. (NYSE:TRMR) announced that Todd Sloan, Senior Vice President and Chief Financial Officer, will step down after a transition period to pursue other opportunities.

Morning Alert: BioLineRx, (NASDAQ:BLRX), Calithera Biosciences (NASDAQ:CALA), Alcatel Lucent SA (ADR) (NYSE:ALU), Demandware (NYSE:DWRE), Pfizer Inc. (NYSE:PFE)

On Friday shares of BioLineRx, Ltd. (NASDAQ:BLRX) closed at $2.15. Israeli biopharmaceutical company BioLineRX Ltd, Ltd. (NASDAQ:BLRX) said on Wednesday an early stage trial for a drug that uses stem cells to treat leukemia and other blood cancers met all safety and efficacy goals.

Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity advanced 9.89% to close at $17.45. Company weekly performance is 10.79% while its quarterly performance stands at -21.85%. Calithera Biosciences, Inc. (NASDAQ:CALA) is -47.88% away from its 52 week high. Calithera Biosciences Inc. (NASDAQ: CALA) recently announced its financial results for the fiscal fourth quarter and year ended December 31, 2014. General and administrative expenses for the full year 2014 were $5.4 million, compared with $2.5 million in the prior year

Alcatel Lucent SA (ADR) (NYSE:ALU) has institutional ownership stands at 4.60%. In last trading activity company’s stock closed at $3.70. Bell Labs, the industrial research arm of Alcatel-Lucent SA (ADR) (NYSE:ALU), announced it has launched a discrete consulting division that is committed to apply analysis, experience and techno-economic modeling tools to some of the key challenges facing the IT and communications networking industry today.

Demandware, Inc. (NYSE:DWRE) has 0.90% insider ownership while its institutional ownership stands at 96.00%. In last trading activity company’s stock closed at $62.02. Analysts at TheStreet upgraded shares of Demandware, Inc. (NYSE:DWRE) from a “sell” rating to a “hold” rating in a research note on Monday, March 16th.

On last trading day Pfizer Inc. (NYSE:PFE) advanced 1.08% to close at $34.53. Its volatility for the week is 1.75% while volatility for the month is 1.51%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is -0.17%. On 24 March 2015, Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.

Healthcare Gainers: Calithera Biosciences (NASDAQ:CALA), ImmunoGen (NASDAQ:IMGN), NephroGenex (NASDAQ:NRX), PhotoMedex (NASDAQ:PHMD), Kamada (NASDAQ:KMDA)

On Monday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $18.74. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA), announced that the Company’s fourth quarter and year-end 2014 financial results will be released on Thursday, March 26, 2015.

ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity increased 16.80% to close at $8.69. Company weekly performance is 12.86% while its quarterly performance stands at -19.91%. ImmunoGen, Inc. (NASDAQ:IMGN) is -48.18% away from its 52 week high. ImmunoGen, Inc. (NASDAQ: IMGN), announced the presentations on Company and partner programs to be made at the upcoming American Association for Cancer Research (AACR) annual meeting to be held April 18-22, 2015 in Philadelphia, PA.

On last trading day NephroGenex, Inc. (NASDAQ:NRX) increased 12.82% to close at $8.36. Its volatility for the week is 8.52% while volatility for the month is 8.65%. NephroGenex, Inc. (NASDAQ:NRX) monthly performance is 32.70%. NephroGenex, Inc. (NASDAQ: NRX), will report its fourth quarter and full year 2014 financial results on Tuesday, March 24, 2015 after the U.S. financial markets close.

PhotoMedex, Inc. (NASDAQ:PHMD) has 22.60% insider ownership while its institutional ownership stands at 36.60%. In last trading activity company’s stock closed at $1.96. Shepherd, Finkelman, Miller & Shah, LLP announces that the United States District Court for the Eastern District of Pennsylvania has approved the following announcement of a proposed class action settlement that would benefit purchasers of PhotoMedex, Inc. securities (NASDAQ: PHMD).

On last trading day Kamada Ltd. (NASDAQ:KMDA) increased 8.94% to close at $4.63. Its volatility for the week is 4.03% while volatility for the month is 3.32%. Kamada Ltd. (NASDAQ:KMDA) monthly performance is 1.31%. Kamada Ltd. (NASDAQ:KMDA) announces that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA), has designated the Company’s proprietary human intrevenous (IV) Alpha-1 Antitrypsin (AAT) as an orphan medicinal product to treat Graft-versus-host disease (GvHD). In October 2014 Kamada received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its AAT by IV to treat GvHD.

Top News: Calithera Biosciences (NASDAQ:CALA), Actinium Pharmaceuticals (NYSEMKT:ATNM), Vodafone Group Plc (ADR) (NASDAQ:VOD), Urban Outfitters (NASDAQ:URBN), The Boeing Company (NYSE:BA)

On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $14.07. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA) announced the upcoming presentation of five preclinical abstracts, highlighting the potential of CB-839, the Company’s novel, orally bioavailable glutaminase inhibitor, at the American Association for Cancer Research, taking place April 18-22, 2015 in Philadelphia, Pennsylvania. Details for the two oral presentations and three poster presentations are as follows:

Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) in last trading activity fell -6.06% to close at $2.79. Company weekly performance is -1.06% while its quarterly performance stands at -50.44%. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is -81.40% away from its 52 week high. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) announced the completion of the third cohort of the Company’s ongoing multi-center Phase 1/2 Study for Actimab-A for the treatment of newly diagnosed Acute Myeloid Leukemia (AML) in elderly patients.

On Thursday shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) closed at $33.15. Company’s sales growth for last 5 years was -1.30%.Espirito Santo Investment Bank Research reaffirmed their sell rating on shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) in a report released on Friday. Espirito Santo Investment Bank Research currently has a GBX 180 ($2.66) price objective on the stock.

Urban Outfitters Inc. (NASDAQ:URBN) has 23.70% insider ownership while its institutional ownership stands at 79.10%. In last trading activity company’s stock closed at $46.70. On March 9, Urban Outfitters, Inc. (NASDAQ:URBN) announced net income of $80 million and $232 million for the three months and year ended January 31, 2015, respectively. Earnings per diluted share were $0.60 and $1.68 for the three months and year ended January 31, 2015, respectively.

The Boeing Company (NYSE:BA) in last trading activity moved down -1.04% to close at $154.11. Company weekly performance is 1.36% while its quarterly performance stands at 24.80%. The Boeing Company (NYSE:BA) is -2.97% away from its 52 week high. The Boeing Company (NYSE:BA) named Jeff Johnson, vice president, Business Development, Boeing Military Aircraft (BMA). He succeeds Tim Norgart, who recently retired from Boeing. Johnson will be based in St. Louis, Missouri, and report to BMA President Shelley Lavender.